Imperial College London

ProfessorUtaGriesenbach

Faculty of MedicineNational Heart & Lung Institute

Professor of Molecular Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 7927u.griesenbach

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Griesenbach:2015:10.1164/rccm.201506-1193LE.,
author = {Griesenbach, U and Alton, EWFW and Boyd, AC and Davies, G and Davies, JC and Gill, DR and Higgins, TE and Hyde, SC and Innes, JA and Porteous, DJ},
doi = {10.1164/rccm.201506-1193LE.},
journal = {American Journal of Respiratory and Critical Care Medicine},
pages = {1389--1392},
title = {A Phase I/IIa safety and efficacy study of nebulized liposome-mediated gene therapy for cystic fibrosis supports a multidose trial},
url = {http://dx.doi.org/10.1164/rccm.201506-1193LE.},
volume = {192},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Griesenbach,U
AU - Alton,EWFW
AU - Boyd,AC
AU - Davies,G
AU - Davies,JC
AU - Gill,DR
AU - Higgins,TE
AU - Hyde,SC
AU - Innes,JA
AU - Porteous,DJ
DO - 10.1164/rccm.201506-1193LE.
EP - 1392
PY - 2015///
SN - 1535-4970
SP - 1389
TI - A Phase I/IIa safety and efficacy study of nebulized liposome-mediated gene therapy for cystic fibrosis supports a multidose trial
T2 - American Journal of Respiratory and Critical Care Medicine
UR - http://dx.doi.org/10.1164/rccm.201506-1193LE.
UR - http://hdl.handle.net/10044/1/27702
VL - 192
ER -